T2 BIOSYSTEMS (TTOO) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 115 213 sessions, October 1, 2025 to October 1, 2026
- Largest daily move
- +3733.3% close of December 24, 2025
- 1-year change
- -95.2% closing prices, October 1, 2025 to October 1, 2026
- 1-month change
- -40% closing prices, September 1, 2026 to October 1, 2026
Company Description
T2 BIOSYSTEMS (OTC: TTOO) is classified in the diagnostics & research industry within the Healthcare sector.
TTOO has declined 95.2% over the past year. The last closing price was $0.0006.
For FY2023, T2 BIOSYSTEMS reported revenue of $7.2M with net income of -$50.1M and diluted earnings per share of -$19.19. The company operates at a net profit margin of -696.2%.
This page collects what Stock Titan holds for TTOO, including price data, latest news, SEC filings, financial highlights, and short interest trends.
Stock Performance
T2 BIOSYSTEMS (TTOO) closed at $0.0006 on October 1, 2026. Over the past 12 months, the price has lost 95.2%.
TTOO Metrics & Rankings
Price returns through October 1, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
T2 BIOSYSTEMS has 10 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 6 with negative movement. Key topics include earnings, conferences, AI, fda approval. View all TTOO news →
SEC Filings
T2 BIOSYSTEMS has filed 1 recent SEC filing, including 1 Form 25-NSE. The most recent filing was submitted on July 10, 2025. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all TTOO SEC filings →
Financial Highlights
T2 BIOSYSTEMS generated $7.2M in revenue in FY2023, operating income reached -$49.7M (-690.4% operating margin), and net income was -$50.1M, reflecting a -696.2% net profit margin. Diluted earnings per share stood at -$19.19. The company generated -$48.1M in operating cash flow. The current ratio was 0.45, measuring current assets divided by current liabilities.
Upcoming Events
Short Interest History
Short interest in T2 BIOSYSTEMS (TTOO) currently stands at 4.9 thousand shares, representing 0.0% of the float.
Days to Cover History
Days to cover for T2 BIOSYSTEMS (TTOO) currently stands at 1.0 days. The ratio is the reported short interest divided by the average daily trading volume. Across the settlements charted above, it has ranged from 1.0 to 3.5 days.
TTOO Company Profile & Sector Positioning
T2 BIOSYSTEMS (TTOO) operates in the Diagnostics & Research industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing TTOO often look at related companies in the same sector, including RUSHNET INC (RSHN), IDENTA CORP (IDTA), INTERPACE BIOSCIENCES NEW (IDXG), INVITRO INTL (IVRO), and CELLBXHEALTH PLC (ANPCF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate TTOO's relative position within its industry.